In vivo experimental evidence that the nitric oxide pathway is involved in the X-ray-induced antiangiogenicity.
We have investigated both the effects of X-rays on angiogenesis and the possible role of nitric oxide (NO) on the observed antiangiogenic effect of X-rays, using as an in vivo model the chick embryo chorioallantoic membrane (CAM). These effects were assessed both morphologically and biochemically, by measuring vascular density and collagenous protein biosynthesis, respectively, on days 9 and 14 of the chick embryo development. Vascular density and cytotoxicity of the CAM were also evaluated histologically. We have shown that X-rays have an antiangiogenic effect on the system used and that the NO synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME) promoted angiogenesis of the non-irradiated CAM and reversed the antiangiogenic effect of irradiation. D-NAME, which is an inactive enantiomer of L-NAME, showed no such effects. L-Arginine, which is the substrate for NO synthase, had a modest antiangiogenic effect on the non-irradiated CAM, no effect on the irradiated CAM and abolished the angiogenic effect of L-NAME on these CAM preparations. These results suggest that NO is involved in the antiangiogenic mechanism of X-rays and that pharmacological manipulation of NO firstly, may offer a better understanding of these mechanisms and, secondly, may also prove to be an alternative therapeutic approach for treating pathological conditions involving angiogenesis.
Hatjikondi
O
O
Department of Radiology, School of Medicine, University of Patras, Greece.
Ravazoula
P
P
Kardamakis
D
D
Dimopoulos
J
J
Papaioannou
S
S
D000818:Animals; D001120:Arginine / Q000494:pharmacology; D002642:Chick Embryo; D002823:Chorion / Q000098:blood supply* / Q000473:pathology / Q000528:radiation effects*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D008833:Microcirculation / Q000187:drug effects / Q000528:radiation effects; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology*; D009389:Neovascularization, Pathologic / Q000188:drug therapy / Q000503:physiopathology*; D018919:Neovascularization, Physiologic / Q000528:radiation effects*; D009569:Nitric Oxide / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D014964:X-Ray Therapy / Q000379:methods
D004791:Enzyme Inhibitors; D009569:Nitric Oxide; D001120:Arginine; D019001:Nitric Oxide Synthase; D019331:NG-Nitroarginine Methyl Ester